Suprachoroidal Gene Therapy for Neovascular AMD
Feb 17, 2022•12 min•Ep. 43
Episode description
Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.
For the best experience, listen in Metacast app for iOS or Android
